Literature DB >> 23539430

Long-term sequelae of childhood bacterial meningitis.

Lee D Hudson1, Russell M Viner, Deborah Christie.   

Abstract

In most high-income countries, fewer children now acquire meningitis, and many of those who do will survive. Globally, however, meningitis still remains a significant cause of child morbidity and mortality. In this article, the authors review recent evidence on the morbidity faced by childhood survivors of bacterial meningitis. Outcomes vary by bacterial pathogen, with around a 20 % risk for severe sequelae (most commonly, neurocognitive) by all pathogenic causes. Pneumococcal, tuberculosis, and group B streptococcal meningitis lead to the highest rates of sequelae. Recent epidemiological shifts in the major pathogens causing meningitis, as well as varied regional settings between studies, limit generalizability of evidence in the literature, and better research using longitudinal data and case-control methodology is required, especially in low-income countries. However, the consistently high levels of complications described in the literature call for more widespread vaccination programs for prevention and a greater focus on potential complications by educators and health-care providers to support childhood survivors of bacterial meningitis and their families.

Entities:  

Year:  2013        PMID: 23539430     DOI: 10.1007/s11908-013-0332-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  38 in total

1.  Pneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999-2007.

Authors:  J M Lucey; P Gavin; M Cafferkey; K M Butler
Journal:  Ir J Med Sci       Date:  2010-11-12       Impact factor: 1.568

Review 2.  Conquering the meningococcus.

Authors:  David S Stephens
Journal:  FEMS Microbiol Rev       Date:  2007-01       Impact factor: 16.408

3.  Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery.

Authors:  R Booy; P Habibi; S Nadel; C de Munter; J Britto; A Morrison; M Levin
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

4.  Health related quality of life in survivors of pneumococcal meningitis.

Authors:  Rosa Legood; Pietro G Coen; Kyle Knox; Russell M Viner; Haitham El Bashir; Deborah Christie; Bharat C Patel; Robert Booy
Journal:  Acta Paediatr       Date:  2008-11-30       Impact factor: 2.299

5.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

6.  Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials.

Authors:  M H Lebel; B J Freij; G A Syrogiannopoulos; D F Chrane; M J Hoyt; S M Stewart; B D Kennard; K D Olsen; G H McCracken
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

7.  Early outcomes of group B streptococcal meningitis in the 21st century.

Authors:  Fatma Levent; Carol J Baker; Marcia A Rench; Morven S Edwards
Journal:  Pediatr Infect Dis J       Date:  2010-11       Impact factor: 2.129

8.  Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.

Authors:  Hannah T Jordan; Monica M Farley; Allen Craig; Janet Mohle-Boetani; Lee H Harrison; Susan Petit; Ruth Lynfield; Ann Thomas; Shelley Zansky; Kenneth Gershman; Bernadette A Albanese; William Schaffner; Stephanie J Schrag
Journal:  Pediatr Infect Dis J       Date:  2008-12       Impact factor: 2.129

9.  Risk factors for death and severe sequelae in Malawian children with bacterial meningitis, 1997-2010.

Authors:  David W McCormick; Mark L Wilson; Limangeni Mankhambo; Ajib Phiri; Yamikani Chimalizeni; Kondwani Kawaza; Brigitte Denis; Enitan D Carrol; Elizabeth M Molyneux
Journal:  Pediatr Infect Dis J       Date:  2013-02       Impact factor: 2.129

Review 10.  Prospects for eradication of meningococcal disease.

Authors:  Simon Nadel
Journal:  Arch Dis Child       Date:  2012-09-15       Impact factor: 3.791

View more
  1 in total

1.  Clinical features to distinguish meningitis among young infants at a rural Kenyan hospital.

Authors:  Christina W Obiero; Neema Mturi; Salim Mwarumba; Moses Ngari; Charles Newton; Michael Boele van Hensbroek; James Alexander Berkley
Journal:  Arch Dis Child       Date:  2020-08-20       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.